AEON Biopharma, Inc.

AEON · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$5-$7$9$2
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$2$2$1
Change in WC$1$1-$6$3
Other Non-Cash$1$2-$13-$7
Operating Cash Flow-$3-$2-$8-$1
Investing Activities
PP&E Inv.$0$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$18$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$18$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$3-$2$10-$1
Supplemental Information
Beg. Cash$8$10$0$1
End Cash$6$8$10$0
Free Cash Flow-$3-$2-$8-$1
AEON Biopharma, Inc. (AEON) Financial Statements & Key Stats | AlphaPilot